ZA956929B - Adhesion receptor antagonists - Google Patents
Adhesion receptor antagonistsInfo
- Publication number
- ZA956929B ZA956929B ZA956929A ZA956929A ZA956929B ZA 956929 B ZA956929 B ZA 956929B ZA 956929 A ZA956929 A ZA 956929A ZA 956929 A ZA956929 A ZA 956929A ZA 956929 B ZA956929 B ZA 956929B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor antagonists
- adhesion receptor
- ala
- phenyl
- formula
- Prior art date
Links
- 102000019997 adhesion receptor Human genes 0.000 title 1
- 108010013985 adhesion receptor Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- VEFFNECIDVRBTE-UHFFFAOYSA-N 2-oxo-3-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound O=C1OC(C(=O)O)CN1C1=CC=CC=C1 VEFFNECIDVRBTE-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4429461A DE4429461A1 (de) | 1994-08-19 | 1994-08-19 | Adhäsionsrezeptor-Antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA956929B true ZA956929B (en) | 1996-03-29 |
Family
ID=6526098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA956929A ZA956929B (en) | 1994-08-19 | 1995-08-18 | Adhesion receptor antagonists |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5614535A (cs) |
| EP (1) | EP0697408B1 (cs) |
| JP (1) | JP3810833B2 (cs) |
| KR (1) | KR100365870B1 (cs) |
| CN (1) | CN1204889C (cs) |
| AT (1) | ATE212339T1 (cs) |
| AU (1) | AU698412B2 (cs) |
| CA (1) | CA2156360C (cs) |
| CZ (1) | CZ290984B6 (cs) |
| DE (2) | DE4429461A1 (cs) |
| DK (1) | DK0697408T3 (cs) |
| ES (1) | ES2170114T3 (cs) |
| HU (1) | HU223844B1 (cs) |
| NO (1) | NO305206B1 (cs) |
| PL (1) | PL182615B1 (cs) |
| PT (1) | PT697408E (cs) |
| RU (1) | RU2156765C2 (cs) |
| SK (1) | SK281754B6 (cs) |
| TW (1) | TW425392B (cs) |
| UA (1) | UA35607C2 (cs) |
| ZA (1) | ZA956929B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| US7049140B1 (en) * | 1999-04-29 | 2006-05-23 | Vanderbilt University | X-ray guided drug delivery |
| DE19958153A1 (de) * | 1999-12-03 | 2001-06-07 | Yamanouchi Pharma Co Ltd | Oxazolidinon-Derivate |
| DE10105989A1 (de) | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| US7306925B2 (en) * | 2001-11-09 | 2007-12-11 | Vanderbilt University | Phage antibodies to radiation-inducible neoantigens |
| US7906102B2 (en) | 2001-10-03 | 2011-03-15 | Vanderbilt University | Ligands to radiation-induced molecules |
| AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| CA2515311A1 (en) * | 2003-02-07 | 2004-08-19 | Warner-Lambert Company Llc | Antibacterial agents |
| US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
| EP1660488A1 (en) * | 2003-08-25 | 2006-05-31 | Warner-Lambert Company LLC | Novel antimicrobial aryloxazolidinone compounds |
| US7304050B2 (en) | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
| PT2484365E (pt) | 2004-06-04 | 2013-12-12 | Scripps Research Inst | Composições e métodos para o tratamento de doenças neovasculares |
| WO2013019730A1 (en) | 2011-07-29 | 2013-02-07 | The Washington University | Antibodies to tip-1 and grp78 |
| EP3172222A4 (en) | 2014-07-24 | 2018-03-21 | Washington University | Compositions targeting radiation-induced molecules and methods of use thereof |
| EP3634459A4 (en) | 2017-02-10 | 2021-01-06 | Washington University | ANTIBODIES DIRECTED AGAINST TIP1 AND THEIR PROCEDURES FOR USE |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2437388A (en) * | 1948-03-09 | Z-oxazolidone compounds and proc | ||
| FR2068423A1 (en) * | 1969-11-06 | 1971-08-27 | Delalande Sa | 3-phenyl-5-ethoxycarbonyl-2-oxazolidinones antiarrhythmics |
| FR2608604B1 (fr) * | 1986-12-19 | 1989-04-28 | Delalande Sa | Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique |
| US4866182A (en) * | 1988-02-18 | 1989-09-12 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic alkanoyl and aroyl oxazolones |
| US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| EP0417044A3 (en) * | 1989-09-07 | 1991-06-12 | Ciba-Geigy Ag | Oxazolidinones and thiones as plantgrowth regulators |
| FR2653017B1 (fr) * | 1989-10-17 | 1995-05-05 | Delalande Sa | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
| DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
| US5298516A (en) * | 1991-03-27 | 1994-03-29 | Sankyo Company, Limited | Thiazolidone compounds and method of using the same as a vasodilator |
| DE4405633A1 (de) * | 1993-05-01 | 1994-11-03 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| DK0623615T3 (da) * | 1993-05-01 | 1999-12-13 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
| CA2170661A1 (en) * | 1995-03-22 | 1996-09-23 | John K. Thottathil | Novel methods for the preparation of taxanes using oaxzolidine intermediates |
-
1994
- 1994-08-19 DE DE4429461A patent/DE4429461A1/de not_active Withdrawn
-
1995
- 1995-07-05 TW TW084106938A patent/TW425392B/zh not_active IP Right Cessation
- 1995-08-10 ES ES95112583T patent/ES2170114T3/es not_active Expired - Lifetime
- 1995-08-10 AT AT95112583T patent/ATE212339T1/de not_active IP Right Cessation
- 1995-08-10 PT PT95112583T patent/PT697408E/pt unknown
- 1995-08-10 EP EP95112583A patent/EP0697408B1/de not_active Expired - Lifetime
- 1995-08-10 DK DK95112583T patent/DK0697408T3/da active
- 1995-08-10 DE DE59510010T patent/DE59510010D1/de not_active Expired - Lifetime
- 1995-08-11 UA UA95083785A patent/UA35607C2/uk unknown
- 1995-08-11 SK SK1001-95A patent/SK281754B6/sk unknown
- 1995-08-14 AU AU28522/95A patent/AU698412B2/en not_active Ceased
- 1995-08-15 CZ CZ19952087A patent/CZ290984B6/cs not_active IP Right Cessation
- 1995-08-17 HU HU9502431A patent/HU223844B1/hu not_active IP Right Cessation
- 1995-08-17 CA CA2156360A patent/CA2156360C/en not_active Expired - Fee Related
- 1995-08-17 CN CNB951152866A patent/CN1204889C/zh not_active Expired - Fee Related
- 1995-08-18 KR KR1019950025388A patent/KR100365870B1/ko not_active Expired - Fee Related
- 1995-08-18 JP JP23210695A patent/JP3810833B2/ja not_active Expired - Fee Related
- 1995-08-18 PL PL95310070A patent/PL182615B1/pl not_active IP Right Cessation
- 1995-08-18 ZA ZA956929A patent/ZA956929B/xx unknown
- 1995-08-18 NO NO953253A patent/NO305206B1/no not_active IP Right Cessation
- 1995-08-18 US US08/516,937 patent/US5614535A/en not_active Expired - Lifetime
- 1995-08-18 RU RU95113863/04A patent/RU2156765C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SK100195A3 (en) | 1996-06-05 |
| EP0697408A1 (de) | 1996-02-21 |
| CA2156360C (en) | 2011-01-11 |
| NO953253L (no) | 1996-02-20 |
| CA2156360A1 (en) | 1996-02-20 |
| DE59510010D1 (de) | 2002-03-14 |
| PL310070A1 (en) | 1996-03-04 |
| NO953253D0 (no) | 1995-08-18 |
| ES2170114T3 (es) | 2002-08-01 |
| KR960007586A (ko) | 1996-03-22 |
| HU9502431D0 (en) | 1996-05-28 |
| US5614535A (en) | 1997-03-25 |
| CZ208795A3 (en) | 1996-06-12 |
| JP3810833B2 (ja) | 2006-08-16 |
| NO305206B1 (no) | 1999-04-19 |
| JPH0892227A (ja) | 1996-04-09 |
| HUT76790A (en) | 1997-11-28 |
| PT697408E (pt) | 2002-07-31 |
| CN1125575A (zh) | 1996-07-03 |
| DE4429461A1 (de) | 1996-02-22 |
| HU223844B1 (hu) | 2005-02-28 |
| CN1204889C (zh) | 2005-06-08 |
| ATE212339T1 (de) | 2002-02-15 |
| RU2156765C2 (ru) | 2000-09-27 |
| AU2852295A (en) | 1996-02-29 |
| AU698412B2 (en) | 1998-10-29 |
| DK0697408T3 (da) | 2002-04-15 |
| SK281754B6 (sk) | 2001-07-10 |
| UA35607C2 (uk) | 2001-04-16 |
| CZ290984B6 (cs) | 2002-11-13 |
| TW425392B (en) | 2001-03-11 |
| KR100365870B1 (ko) | 2003-03-04 |
| PL182615B1 (pl) | 2002-02-28 |
| EP0697408B1 (de) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA956929B (en) | Adhesion receptor antagonists | |
| EP0578083A3 (cs) | ||
| CA2276278A1 (en) | Amine compounds, their production and use | |
| MY125749A (en) | Aralkyl and aralkylidene heterocyclic lactams and imides | |
| AU1651195A (en) | Novel polyenic compounds, pharmaceutical and cosmetic compositions containing them and uses | |
| FI914476A0 (fi) | Tricykliska heterocykliska foereningar. | |
| ES2091359T3 (es) | Nuevo compuesto peptidico y un procedimiento para su preparacion. | |
| IL106387A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
| HUT74014A (en) | Bicyclic aromatic compounds, pharmaceutical and cosmetical compositions containing them, and use of them | |
| WO1998046576A3 (en) | Halo-alkoxycarbonyl prodrugs | |
| MY125562A (en) | Hexahydro-pyrido (4,3-b) indole derivatives as antipsychotic drugs | |
| ES2141096T3 (es) | Compuestos de cefalosporina y composiciones farmaceuticas de los mismos. | |
| MXPA01011955A (es) | Aminoacidos policiclicos, fusionados, como agentes farmaceuticos. | |
| TW333533B (en) | Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase | |
| IL116601A (en) | 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them | |
| AU2351097A (en) | Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use | |
| HUT76480A (en) | Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP9902678A2 (hu) | Protein kináz-C inhibitor hatású, halogénatommal szubsztituált bisz(indol)-maleinmid-származékok, valamint ezeket tartalmazó gyógyászati készítmények | |
| IL113650A0 (en) | 8-amino-10- (azabicycloalkyl)-pyrido [1,2,3-d, e][1,3,4] benzoxadiazine derivatives their preparartion and pharmaceutical compositions containing them | |
| DE69801535D1 (de) | Benzolsulfonylamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| EA199900688A1 (ru) | Хиноксалиндионы | |
| ITRM940273A0 (it) | "nuove composizioni per gunite di riparazione". | |
| PT90831A (pt) | Processo para a preparacao de eteres da 2-amino-7-hidroxitetralina | |
| MY104834A (en) | Ergoline deravatives, processes for their preparation and pharmaceutical compositions containing same. | |
| BG52026B2 (en) | Composition for chemical cleaning of "briz" gun barrels |